Exicure, Inc. - Common Stock (XCUR)
10.65
0.00 (0.00%)
Exicure Inc. is a biotechnology company focused on developing innovative therapies based on its proprietary SNA technology, which utilizes programmable RNA to target and modulate gene expression in various diseases
The company's primary efforts are aimed at treating genetic disorders and cancers by delivering therapeutic agents that can precisely interact with specific RNA molecules. Through advancing its scientific research and clinical development, Exicure aims to address unmet medical needs and improve treatment outcomes for patients.
